Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation

Clinical and Experimental Immunology

Volumn 114, Issue 2, 1998, Pages 137-146

  Brown, J R ^c   Kleimberg, J ^a   Marini, M ^c   Sun, G ^c   Bellini, A ^a   Mattoli, S ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b Avail GmbH   (Switzerland)

^c NONE

Author keywords

Airway allergy; Asthma; Chemokines; Eosinophils; Eotaxin

Indexed keywords

ALLERGEN; CYTOKERATIN; EOTAXIN; MESSENGER RNA;

ADULT; ALLERGIC ASTHMA; ARTICLE; BRONCHOSCOPY; BRONCHUS BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG LAVAGE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY;

ADMINISTRATION, INHALATION; ADULT; ALLERGENS; ASTHMA; BRONCHI; BRONCHOALVEOLAR LAVAGE; CHEMOKINES, CC; CHEMOTACTIC FACTORS, EOSINOPHIL; CYTOKINES; EOSINOPHILS; FEMALE; HUMANS; KINETICS; MALE; MIDDLE AGED;

EID: 0031762458     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00688.x     Document Type: Article

References (43)

1. Bousquet J, Chanez P, Lacoste JY et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323:1033-9.
2. Busse WW, Sedgwick JB. Eosinophils in asthma. Ann Allergy 1992; 68:286-90.
3. Busse WW, Calhoun WF, Sedgwick JB. Mechanisms of airway inflammation in asthma. Am Rev Respir Dis 1993; 147:S20-S24.
4. Seminario M-C, Gleich G. The role of eosinophils in the pathogenesis of asthma. Curr Opin Immunol 1994; 6:860-4.
5. Wardlaw AJ, Moqbel R, Kay AB. Eosinophils: biology and role in disease. Adv Immunol 1995; 60:151-266.
6. Resnick MB, Weller PF. Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol 1993; 8:349-55.
7. Griffiths-Johnson DA, Collins PD, Rossi AG, Jose PJ, Williams TJ. The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem Biophys Res Commun 1993; 197:1167-72.
8. Jose PJ, Griffiths-Johnson DA, Collins PD et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994; 179:881-7.
9. Garcia-Zepada EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nature Med 1996; 2:449-56.
10. Ponath PD, Qin S, Ringler DJ et al. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of cosinophils. J Clin Invest 1996; 97:604-12.
11. Jose PJ, Adcock IM, Griffiths-Johnson DA, Berkman N, Wells TNC, Williams TJ, Power CA. Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs. Biochem Biophys Res Commun 1994; 205:788-94.
12. Rothenberg ME, Luster AD, Lilly CM, Drazen JM, Leder P. Constitutive and allergen-induced expression of eotaxin mRNA in the guinea-pig lung. J Exp Med 1995; 181:1211-6.
13. Gonzalo JA, Jia G-Q, Aguirre V et al. The expression of mouse eotaxin parallels eosinophil accumulation during lung allergic inflammatory reactions but is not restricted to a TH2 type response. Immunity 1996; 4:1-14.
14. Humbles AA, Conroy DM, Marleau S et al. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airway disease: analysis in a guinea pig model in vivo. J Exp Med 1997; 186:601-12.
15. Li D, Wang D, Griffiths-Johnson DA, Wells TNC, Williams TJ, Jose PJ, Jeffery PK. Eotaxin protein and gene expression in guinea-pig lungs: constitutive expression and upregulation after allergen challenge. Eur Respir J 1997; 10:1946-54.
16. Mattoli S, Stacey MA, Sun G, Bellini A, Marini M. Eotaxin expression and eosinophilic inflammation in asthma. Biochem Biophys Res Commun 1997; 236:299-301.
17. Lamkhioued B, Renzi PM, Abi-Younes S et al. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol 1997; 159:4593-601.
18. Ying S, Robinson DS, Meng Q et al. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol 1997; 27:3507-16.
19. O'Byrne PM, Dolovich J, Hargreave FE. Late asthmatic responses. Am Rev Respir Dis 1987; 136:740-51.
20. Lemanske RF, Kaliner MA. Late phase allergic reactions. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF, Yuninger JW, Busse WW, eds. Allergy: principles and practice, 4th edn. St Louis: Mosby Yearbook, 1993:320-61.
21. Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute, National Education program. Expert Panel Report. J Allergy Clin Immunol 1991; 88:425-534.
22. Cockcroft DW, Murdock KY, Kirby J, Hargreave FE. Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine. Am Rev Resp Dis 1987; 135:264-8.
23. Mattoli S, Mattoso VL, Soloperto M, Allegra L, Fasoli A. Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma. J Allergy Clin Immunol 1991; 87:794-802.
24. Ackerman V, Marini M, Vittori E, Bellini A, Vassalli G, Mattoli S. Detection of cytokines and their cell source in bronchial biopsy samples from asthmatic patients. Relationship to the atopic status, symptoms and level of airway hyperresponsiveness. Chest 1994; 105:687-96.
25. Workshop summary and guidelines: investigative use of bronchoscopy, lavage, and bronchial biopsies in asthma and other airway diseases. J Allergy Clin Immunol 1991; 88:808-14.
26. Moqbel R, Barkans J, Bradley BL, Durham SR, Key AB. Application of monoclonal antibodies against major basic protein (BMK-13) and eosinophil cationic protein (EGI and EG2) for quantifying eosinophils in bronchial biopsies from atopic asthma. Clin Exp Allergy 1992; 22:265-73.
27. Tai P-C, Spry CJF, Peterson C, Venge P, Olssen I. Monoclonal antibodies distinguish storage and secreted forms of eosinophil cationic protein. Nature 1984; 309:182-4.
28. Mattoli S, Mezzetti M, Riva G, Allegra L, Fasoli A. Specific binding of endothelin to human bronchial smooth muscle cells in culture and secretion of endothelin-like material from human bronchial epithelial cells. Am J Respir Cell Mol Biol 1990; 3:145-51.
29. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W. Current protocols in immunology. New York: John Wiley and Sons, 1992.
30. Conover WJ. Practical non-parametric statistics. New York: John Wiley and Sons, 1980.
31. Chung KF. The eosinophil in airway inflammation: potential role and pharmacologic modulation. In: Chung KF, Barnes PJ. eds. Pharmacology of the respiratory tract. New York: Marcel Dekker, 1993:303-29.
32. De Monchy JGR, Kauffman HF, Venge P, Koeter GH, Jansen HM, Sluiter HJ, De Vries K. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985; 131:373-6.
33. Aalbers R, De Monchy JGR, Kauffman HF, Smith M, Hoekstra Y, Vrugt B, Timens W. Dynamics of eosinophil infiltration in the bronchial mucosa before and after the late asthmatic reaction. Eur Respir J 1993; 6:840-7.
34. Holgate ST, Bodey KS, Janezic A, Frew AJ, Kaplan AP, Teran LM. Release of RANTES, MIP-1α, and MCP-1 into asthmatic airways following endobronchial allergen challenge. Am J Respir Crit Care Med 1997; 156:1377-83.
35. Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG, Vadas MA. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 1988; 167:219-24.
36. Soloperto M, Mattoso VL, Fasoli A, Mattoli S. A bronchial epithelial cell-derived factor in asthma which promotes eosinophil activation and survival as GM-CSF. Am J Physiol 1991; 260:L530-L538.
37. Sur S, Hirohito K, Gleich GJ, Chenier TC, Hunt LW. Eosinophil recruitment is associated with IL-5, but not with RANTES, twenty-four hours after allergen challenge. J Allergy Clin Immunol 1990; 97:1272-8.
38. Bentley AM, Meng Q, Robinson DS, Hamid Q, Kay AB, Durham SR. Increases in activated T lymphocytes, eosinophils and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Respir Cell Mol Biol 1993; 8:35-42.
39. Ohnishi T, Kita H, Weiler D et al. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am Rev Respir Dis 1993; 147:901-7.
40. Ohnishi T, Sur S, Collins DS, Fish JE, Gleich GJ, Peters SP. Eosinophils survival activity identified as IL-5 is associated with eosinophil recruitment and degranulation and lung injury twenty-tour hours after segmental antigen challenge. J Allergy Clin Immunol 1993; 92:607-15.
41. Woolley KL, Adelroth E, Woolley MJ, Ellis R, Jordana M, O'Byrne PM. Effects of allergen challenge on eosinophils, eosinophil cationic protein, and granulocyte-macrophage colony-stimulating factor in mild asthma. Am J Respir Crit Care Med 1995; 151:1915-24.
42. Shaver JR, Zangrilli JG, Cho S-K, Cirelli RA, Pollice M, Hastie AT, Fish JE, Peters SP. Kinetics of the development and recovery of the lung from IgE-mediated inflammation. Am J Respir Crit Care Med 1997; 155:442-8.
43. Mori L, Kleimberg J, Mancini C, Bellini A, Marini M, Mattoli S. Bronchial epithelial cells of atopic patients with asthma lack the ability to inactivate allergens. Biochem Biophys Res Commun 1995; 217:817-24.